Pharmarise Holdings
2796.TServices
Financials · Consolidated
| Fiscal year ended | 2026-05 | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|---|
| Revenue | ¥69.5bn | ¥63.5bn | ¥54.5bn | ¥52.0bn | ¥51.6bn | ¥52.3bn |
| Operating income | ¥979m | ¥293m | ¥916m | ¥1.4bn | ¥1.5bn | ¥1.2bn |
| Ordinary income | ¥715m | ¥136m | ¥833m | ¥1.4bn | ¥1.5bn | ¥1.3bn |
| Net income (owners) | ¥114m | −¥367m | −¥351m | ¥333m | ¥447m | ¥426m |
| Total assets | ¥32.7bn | ¥31.9bn | ¥29.5bn | ¥23.4bn | ¥23.7bn | ¥24.7bn |
| Net assets / equity | ¥6.9bn | ¥6.9bn | ¥7.4bn | ¥7.0bn | ¥6.7bn | ¥6.3bn |
| Operating cash flow | ¥3.3bn | ¥1.3bn | ¥2.7bn | ¥2.5bn | ¥713m | ¥1.9bn |
| EPS (basic) | ¥10.01 | ¥-32.48 | ¥-33.41 | ¥35.45 | ¥47.99 | ¥45.83 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 6
| Period | Form | Figures |
|---|---|---|
| 2023-06-01 → 2024-02-29 | Quarterly Q3 | 52 figures · EDINET |
| 2023-06-01 → 2023-11-30 | Quarterly Q2 | 76 figures · EDINET |
| 2023-06-01 → 2023-08-31 | Quarterly Q1 | 50 figures · EDINET |
| 2022-06-01 → 2023-02-28 | Quarterly Q3 | 52 figures · EDINET |
| 2022-06-01 → 2022-11-30 | Quarterly Q2 | 76 figures · EDINET |
| 2022-06-01 → 2022-08-31 | Quarterly Q1 | 50 figures · EDINET |
23 more reports are still being processed.
Segments · FY ended 2026-05
| Segment | External sales | Profit |
|---|---|---|
| Cosmetic Drug And Convenience Store | ¥8.0bn | −¥83m |
| Custody Of Medical Documents | ¥647m | ¥100m |
| Dispensing Pharmacy | ¥59.3bn | ¥1.4bn |
| Medical Mall | ¥505m | ¥87m |
| Other segments | ¥986m | −¥113m |
| Adjustments & eliminations | — | −¥397m |
| Total | ¥68.5bn | ¥1.5bn |
| Total | ¥69.5bn | ¥1.4bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.